Alaa Elmazny

453 total citations
33 papers, 304 citations indexed

About

Alaa Elmazny is a scholar working on Pathology and Forensic Medicine, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Alaa Elmazny has authored 33 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 13 papers in Psychiatry and Mental health and 10 papers in Neurology. Recurrent topics in Alaa Elmazny's work include Multiple Sclerosis Research Studies (15 papers), Migraine and Headache Studies (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Alaa Elmazny is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Migraine and Headache Studies (6 papers) and Peripheral Neuropathies and Disorders (5 papers). Alaa Elmazny collaborates with scholars based in Egypt, Bahrain and Saudi Arabia. Alaa Elmazny's co-authors include Nevin Shalaby, Hatem Shehata, Ahmed Abdelalim, Rehab Magdy, Nirmeen A. Kishk, Amr Hassan, Mohamed Hegazy, Maged Abdel Naseer, Sherif Hamdy and Amira A. Shaheen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Headache The Journal of Head and Face Pain and Epilepsy & Behavior.

In The Last Decade

Alaa Elmazny

29 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alaa Elmazny Egypt 11 128 88 79 57 55 33 304
Maged Abdel Naseer Egypt 11 84 0.7× 36 0.4× 45 0.6× 42 0.7× 72 1.3× 28 282
Sidney Gomes Brazil 11 166 1.3× 42 0.5× 115 1.5× 54 0.9× 21 0.4× 22 311
Hatem Shehata Egypt 11 220 1.7× 120 1.4× 149 1.9× 21 0.4× 60 1.1× 35 361
Marcin Wnuk Poland 11 31 0.2× 29 0.3× 109 1.4× 41 0.7× 24 0.4× 35 299
Jorge Millán‐Pascual Spain 13 167 1.3× 42 0.5× 150 1.9× 62 1.1× 13 0.2× 28 394
Fernando Monsalve Iglesias Spain 9 158 1.2× 180 2.0× 131 1.7× 43 0.8× 17 0.3× 22 374
Miklós Bánáti Hungary 10 128 1.0× 32 0.4× 58 0.7× 47 0.8× 72 1.3× 15 409
Ömer Faruk Turan Türkiye 9 84 0.7× 19 0.2× 27 0.3× 41 0.7× 15 0.3× 36 229
Caren Ramien Germany 10 181 1.4× 23 0.3× 35 0.4× 48 0.8× 50 0.9× 13 337
Constantinos Sfagos Greece 10 111 0.9× 30 0.3× 86 1.1× 60 1.1× 27 0.5× 17 309

Countries citing papers authored by Alaa Elmazny

Since Specialization
Citations

This map shows the geographic impact of Alaa Elmazny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Elmazny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Elmazny more than expected).

Fields of papers citing papers by Alaa Elmazny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Elmazny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Elmazny. The network helps show where Alaa Elmazny may publish in the future.

Co-authorship network of co-authors of Alaa Elmazny

This figure shows the co-authorship network connecting the top 25 collaborators of Alaa Elmazny. A scholar is included among the top collaborators of Alaa Elmazny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaa Elmazny. Alaa Elmazny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zakaria, Magd, Nevin Shalaby, Alaa Elmazny, et al.. (2025). Development and validation of a scoring system for predicting disease activity in treatment-naïve patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 94. 106278–106278. 1 indexed citations
3.
Magdy, Rehab, et al.. (2025). Public knowledge about Alzheimer’s disease in Egypt: a cross-sectional survey. Aging Clinical and Experimental Research. 37(1). 163–163.
4.
Elmazny, Alaa, et al.. (2024). Public misconceptions and attitudes towards persons diagnosed with epilepsy in the Kingdom of Bahrain: A cross-sectional study. Epilepsy & Behavior. 153. 109731–109731. 3 indexed citations
5.
Shehata, Hatem, Sherif Hamdy, Maged Abdel Naseer, et al.. (2024). Effect of high frequency repetitive transcranial magnetic stimulation (rTMS) on the balance and the white matter integrity in patients with relapsing-remitting multiple sclerosis: A long-term follow-up study. Multiple Sclerosis and Related Disorders. 83. 105471–105471. 5 indexed citations
6.
Elmazny, Alaa, et al.. (2023). Knowledge, awareness, and attitudes towards epilepsy among elementary schoolteachers in the Kingdom of Bahrain. European Journal of Paediatric Neurology. 47. 13–17. 6 indexed citations
8.
Elmazny, Alaa, et al.. (2023). Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination. European Archives of Psychiatry and Clinical Neuroscience. 273(6). 1349–1358. 11 indexed citations
10.
Hassan, Amr, et al.. (2021). Co-Occurrence of Guillain-Barre Syndrome and Multiple Sclerosis: A Rare Case Report. SHILAP Revista de lepidopterología. 4(1). 31–35. 2 indexed citations
11.
Langdon, Dawn, Nevin Shalaby, Hatem Shehata, et al.. (2021). Reliability and validity of Arabic version of the brief international cognitive assessment for multiple sclerosis: Egyptian dialect. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 57(1). 19 indexed citations
12.
Kishk, Nirmeen A., Nevin Shalaby, Hatem Shehata, et al.. (2021). The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt. BMC Neurology. 21(1). 53–53. 3 indexed citations
13.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach</p>. Therapeutics and Clinical Risk Management. Volume 16. 651–662. 11 indexed citations
14.
Hamdy, Sherif, Maged Abdel Naseer, Hatem Shehata, et al.. (2020). <p>Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era</p>. Therapeutics and Clinical Risk Management. Volume 16. 759–767. 3 indexed citations
15.
Okasha, Hussein, et al.. (2020). Comparative study of tissue adhesive therapy versus band ligation in control of actively bleeding esophageal varices.. PubMed. 83(1). 5–10. 6 indexed citations
16.
Elmazny, Alaa, et al.. (2020). Ultraviolet B Radiation Therapy Versus Vitamin D3 Supplementation: Effects on Cognitive Functions and Fatigue in Egyptian Relapsing Remitting Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders. 37. 101605–101605. 2 indexed citations
17.
Elmazny, Alaa, et al.. (2019). Vitamin D status of untreated children and adolescent Egyptian patients with genetic generalized epilepsy: A case–control study. Epilepsy & Behavior. 103(Pt A). 106840–106840. 9 indexed citations
19.
Shehata, Hatem, et al.. (2017). Development and validation of an Arabic-language headache questionnaire for population-based surveys. Journal of Pain Research. Volume 10. 1289–1295. 10 indexed citations
20.
Shehata, Hatem, et al.. (2016). Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial. Journal of Pain Research. Volume 9. 771–777. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026